National Marrow Donor Program

“The following Directors of the NMDP have a reportable business relationship: Anne McGeorge and Amy Ronneberg (Ms. McGeorge and Ms. Ronneberg were both voting directors of Magenta Therapeutics during FY2023). The following Directors of NMDP have a reportable business relationship: Anne McGeorge and Amy Ronneberg (Ms. McGeorge and Ms. Ronneberg were both voting directors of CLEAR Insurance, Ltd. during FY2023).”

“The NMDP Bylaws state: "The Executive Committee shall at all times include the Chair of the Board, the Immediate Past Chair (when in office), the Chair-Elect (when in office), the Secretary, the Chief Executive Officer, and any Government Representatives. Any and all additional members of the Executive Committee shall be Voting Directors, except the Chief Executive Officer and Government Representatives, who shall serve as non-voting ex officio members of the committee. The Executive Committee shall, to the extent allowed by applicable law, have the authority of the Board in the oversight of the business of the Corporation between meetings of the full Board and shall have such other authority and responsibilities as set forth in the Executive Committee Charter." The Executive Committee Charter states: "The Executive Committee shall, to the extent determined by the Board of Directors, have the authority of the Board in the oversight of the business of the Corporation between meetings of the full Board. The Executive Committee shall manage the business of the Corporation and direct and coordinate the work activities of committees between meetings of the Board. The Executive Committee shall also review key Board-level policies and procedures on a periodic basis and recommend new or modified policies and initiatives. With the Board, the Executive Committee is responsible for oversight of the strategic planning process, developing a calendar for Board activities, and providing guidance to the Board and Corporation staff regarding the appropriate roles of each. The Executive Committee, in close coordination with the Audit & Finance Committee, shall monitor the financial integrity of operations, including evaluating performance against the Corporation's budget and strategic and business plans. In addition, the Executive Committee shall represent the Corporation in its interactions with other organizations, Congress, federal agencies, participating centers, constituent groups, professional organizations, and the public."”

“Form 990 review process: The organization contracted with the outside public accounting firm, Baker Tilly, to prepare the Form 990. Preparing the details and supporting reports for the return is a collaborative effort among a small group of individuals in the financial reporting & compliance area of finance, internal audit and human resources. Once a draft is received back from Baker Tilly, it is reviewed by the team that pulled the details together, Director, Finance and Corporate Controller, and NMDP Chief Financial Officer. The NMDP CHIEF ADMINISTRATIVE OFFICER also reviews the governance sections. A copy of the return is provided to the organization's audit and finance committee and board of directors prior to filing.”

“The Conflict of Interest Policy states the following: "The existence of an actual or potential conflict of interest turns on the specific facts and circumstances in each case. If a Member has an interest which may conflict with those of the Organizations, he or she must immediately disclose the matters and discuss them fully and frankly with the applicable Organization's full Board or its Executive Committee, as set forth in detail below. A Member must not participate in any matter in which that Member may have an actual or potential conflict of interest without the express approval of the applicable Organization's Board of Directors or Executive Committee of the Board of Directors (Executive Committee). All Members must disclose to the applicable Organization's Board of Directors or Executive Committee all conflicts of interest and reportable relationships, and must annually complete and submit the Conflict of Interest Questionnaire which is required by this Policy. Whenever in the course of events a Member's circumstances change such that the Member knows or has reason to believe that the Member may have an actual or perceived conflict of interest, such Member shall promptly disclose the potential conflict to the applicable Organization's Board of Directors or Executive Committee. For the purposes of this Article, a Member may formally disclose a conflict or reportable relationship to the NMDP Chief Executive Officer (CEO), the Chief Advancement Officer, or the NMDP Chief Administrative Officer and General Counsel (CAO), as applicable, who shall inform the applicable Organization's Board of Directors or Executive Committee for resolution. As noted herein, if the potential conflict involves a Director or Committee Member, that Director or Committee Member shall not participate in or vote upon such matters until the question of the existence of the conflict of interest has been resolved in accordance with this Policy. Likewise, an officer or key employee may not become substantially involved in decision-making involving any covered litigation, contract or transaction until the resolution of the matter in accordance with this Policy."”

“The NMDP Bylaws state: "The Compensation Committee shall be comprised only of Voting Directors and shall include the Chair of the Board and at least one (1) non-officer Board member as voting committee members. The Compensation Committee shall review and evaluate the overall compensation and benefit structure of the Corporation and shall have such other authority and responsibilities as set forth in the Compensation Committee Charter." The Compensation Committee Charter states: "The Committee shall review and evaluate the overall compensation and benefit structure of the Corporation, and approve and adopt a compensation philosophy and principles consistent with the Corporation's non-for-profit status (the "Compensation Philosophy and Principles"). The Committee shall conduct the Chief Executive Officer ("CEO") performance evaluation. The Committee shall make CEO total compensation and benefit recommendations to the Executive Committee, consistent with the Compensation Philosophy and Principles. In making compensation and benefit recommendations for the CEO, the Committee shall utilize, among other things, comparability data for compliance with IRS Intermediate Sanction provisions so as to allow the Corporation to take advantage of the rebuttable presumption of reasonableness. On a periodic basis, the Committee shall obtain comparability data from an independent compensation consultant. In addition, the Committee shall advise the CEO in his/her evaluation of and decisions regarding the compensation of and benefits for senior Corporation employees, as well as the President (or equivalent leader) of any subsidiary of the Corporation reporting to the CEO (together, "Senior Leadership"). In advising the CEO in making his/her compensation and benefit decisions for Senior Leadership, the Committee shall ensure that such decisions are consistent with the Compensation Philosophy and Principles, and utilize, among other things, comparability data for compliance with IRS Intermediate Sanction provisions. If decisions proposed by the CEO are outside the parameters of the Compensation Philosophy and Principles, the CEO must obtain the Committee's approval prior to implementation."”

“How documents are made available to the public: The conflict of interest policy, articles of incorporation and consolidated audited financial statements are available to the public upon request. Summary financial statements are also included in our annual report, which is mailed to key stakeholders and posted on our website. Additionally, articles of incorporation are available through the MN office of the secretary of state, and consolidated audited financial statements may be obtained at the MN office of the attorney general.”

“At nmdp, we believe each of us holds the key to curing blood cancers and disorders. As a global nonprofit leader in cell therapy, nmdp creates essential connections between researchers and supporters to inspire action and accelerate innovation to find life-saving cures. With the help of blood stem donors from the world's most diverse registry and our extensive network of transplant parters, physicians and caregivers, we're expanding access to treatment so that every patient can receive their life-saving cell therapy. Nmdp. Find cures. Save lives. . Our mission: we save lives through cell therapy. Our vision: create a world where every patient can receive their life-saving cell therapy. The nmdp foundation raises funds for three programs critical to our life-saving mission: transplant research, patient financial assistance and donor recruitment. Some of the life-changing work that we're doing is soley funding by our community of supporters. We conduct research through our research program, cibmtr (center for international blood and marrow transplant research) in collaboration with the medical college of wisconsin. Our research leads to more lives saved and an enriched quality of life for thousands of patients. Through the nmdp amy strelzer manasevit research program and other research grants, outstanding early-career researchers are doing innovative work to find solutions to the complications that can arise after transplant. They're developing treatment approaches that will help the next generation of transplant patients live longer, healthier lives. Patient financial assistance helps cover transplant-related costs not covered by insurance that cause significant hardship or even prevent patients from moving forward with transplant. Costs like transportation, lodging, lost wages and prescriptions. Nmdp connects patients with a matching, unrelated donor, a selfless stranger who can step up and donate their healthy blood stem cells to give them the chance at a life-saving transplant.”

“(Expenses $ 22,381,318 including grants of $ 2,269,711)(Revenue $ 70,427) PUBLIC AWARENESS: NMDP PARTNERS WITH NMDP FOUNDATION TO ADVANCE VARIOUS INITIATIVES TIED TO THE SHARED MISSION. THESE PROGRAMS INCLUDE: NMDP PROVIDES COMPREHENSIVE EDUCATION AND SUPPORT SERVICES TO PATIENTS AND THEIR FAMILIES THROUGH ONE-ON-ONE NAVIGATION SUPPORT, VIDEO, PRINTED, AND DIGITAL EDUCATION RESOURCES, COUNSELING, NMDP PEER CONNECT PROGRAM, NMDP SURVIVORSHIP PROGRAM, NMDP SICKLE CELL WARRIOR PROGRAM, AND THE JASON CARTER CLINICAL TRIALS SEARCH AND SUPPORT PROGRAM, WHICH HELPS PATIENTS WITH LIFE-THREATENING BLOOD DISORDERS FIND CLINICAL TRIALS. NMDP Foundation RAISES FUNDS TO SUPPORT THESE CRITICAL SERVICES.”

“The organization has neither changed its oversight process or selection process during the tax year.”

“The return for the current year is being amended to reflect the following: 1. Form 990, part vii, section a, lines 1a, 1b, and 1d column (f) are revised to reflect the accurate compensation reporting for the fiscal year. After filing form 990, it was discovered the organization erroneously failed to include in column (f) the amount earned by eligible individuals under the organization's long-term incentive plan. 2. After filing form 990, it was discovered the compensation for m. Mccullough and j. Smolich were inadvertently switch. This amendment corrects the compensation reporting for each employee. 3. Schedule j part ii, column (c), column (e), and column (f) are revised to reflect the accurate reporting of compensation and deferred compensation for the period. Amounts deferred and paid under the organization's long-term incentive plan were erroneously excluded from the filing. This amendment corrects the inadvertent error. See schedule j part iii line 7 for additional disclosures.”